Bavarian Nordic — September 2023
-
Bavarian endte i toppen af C25-indekset med en stigning på 3,1 pct. til 158,50 kr.
-
Aktien søger efter sin identitet, vurderer Lars Hytting og fortsætter:
-
Er det et medicinalselskab, et vaccineselskab eller et biotekselskab. Det afhænger prissætningen af, og markedet generelt har endnu ikke lagt sig fast på det. Derfor svinger
Bavarian-kursen lystigt.
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind